Frank Donatello, DO
Family Medicine · Oak Forest, ILNPI 1801843156
Payments from drug & device makers
Across 395 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$1K
- AbbVie$843
- Lilly USA, LLC$769
- Amgen$462
- Pfizer$386
- plus $2K from 28 others
What the payments were for
- Food & beverage$7,090100%
- Education$230%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 88 | $1,384 |
| AstraZeneca | 58 | $1,076 |
| AbbVie(2 entities) | 46 | $843 |
| Lilly USA, LLC | 45 | $769 |
| Amgen | 25 | $462 |
| Pfizer | 21 | $386 |
| GSK | 22 | $378 |
| Bayer | 11 | $260 |
| Johnson & Johnson | 11 | $253 |
| Exact Sciences | 8 | $143 |
| Radius Health, Inc. | 5 | $134 |
| E.r. Squibb & Sons, L.L.C. | 7 | $124 |
| Otsuka America Pharmaceutical, Inc. | 4 | $103 |
| Amarin Pharma, Inc. | 5 | $100 |
| Sanofi-aventis U.S. LLC | 5 | $82 |
| Biohaven Pharmaceuticals, Inc. | 3 | $57 |
| Merck | 4 | $55 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $54 |
| Amneal Pharmaceuticals LLC | 3 | $53 |
| CSL Behring | 2 | $47 |
| Idorsia Pharmaceuticals US Inc | 3 | $46 |
| Hikma Pharmaceuticals USA | 2 | $42 |
| Supernus Pharmaceuticals, Inc. | 1 | $38 |
| Novartis | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Boehringer Ingelheim | 1 | $26 |
| Philips North America LLC | 1 | $21 |
| Abbott | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Shire North American Group Inc | 1 | $13 |
| Almatica Pharma LLC | 1 | $13 |
How this compares
$7,113 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 102 | $72,916 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $23,066 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 25 | $15,134 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 63 | $11,714 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 22 | $6,896 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,754 |
| DuleraMometasone/Formoterol | 13 | $4,701 |
| Dofetilide | 29 | $4,681 |
| Incruse ElliptaUmeclidinium Bromide | 14 | $4,146 |
| Levothyroxine Sodium | 212 | $2,600 |
| Metoprolol Succinate | 127 | $2,023 |
| Atorvastatin Calcium | 223 | $1,909 |
| Pravastatin Sodium | 72 | $1,566 |
| Testosterone | 15 | $1,365 |
| Lisinopril | 151 | $1,355 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $386 | $72,916102 claims |
| AstraZenecaBreztri Aerosphere | $1,076 | $15,13425 claims |
| GSKBreo Ellipta, Incruse Ellipta | $378 | $8,90026 claims |
| MerckDulera | $55 | $4,70113 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $53 | $2,600212 claims |
| AbbVieSynthroid | $843 | $75813 claims |
| Almatica Pharma LLCSertraline Hcl | $13 | $61354 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Oak Forest
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.